New study: Blocking myostatin with apitegromab helps tirzepatide users lose more fat while keeping lean muscle. 💪🔬
www.news-medical.net/news/2026060... #Apitegromab #LeanMass #ClinicalTrials
A phase 2 trial found that apitegromab plus tirzepatide reduced lean body mass loss by 1.9 kg compared with tirzepatide plus placebo after 24 weeks, while overall weight loss remained similar.
